Jackson B. Beecham - Concepedia

Author

Jackson B. Beecham

University of Rochester Medical Center

Also Known As

J B Beecham, J Beecham, J. BEECHAM, J. Beecham, J.B. Beecham, JACKSON B. BEECHAM, Jackson B. Beecham, Jackson Beecham

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Medical Center Gynecologic Oncology Group University of Rochester Norwegian Cancer Society Medical University of South Carolina

About

Jackson B. Beecham is an author at University of Rochester Medical Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.6K
2	Public Health	2	2	192
3	Arts	1	1	23
4	Health Sciences	1	1	15
5	Anatomy	1	1	33

Jackson B. Beecham

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. G A Omura, John A. Blessing, Francis J. Major, Journal of Clinical Oncology Uterine SarcomasRandomized Clinical TrialSurgical OncologyGynecological SurgeryCervical Cancer	1985	393
Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up Jan Trygve Stenwig, Johan The. Hazekamp, Jackson B. Beecham Gynecologic Oncology Surgical PathologyGynecologyPathologyGranulosa Cell TumorsClinicopathological Study	1979	246
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients Kenneth D. Hatch, Jackson B. Beecham, John A. Blessing, Cancer Estrogen ReceptorsEstrogen Receptor LevelsMedicineCancer ManagementGynecology	1991	207
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J.T. Thigpen, John A. Blessing, Jackson B. Beecham, Journal of Clinical Oncology Surgical OncologyPhase Ii TrialCisplatin 50MedicineSurgical Pathology	1991	166
Distribution of disease at autopsy in 100 women with ovarian cancer Philip M. Dvoretsky, Keith Richards, Cynthia Angel, Human Pathology Tumoral PathologyCancer EpidemiologyMedicineEpidemiology Of CancerPathology	1988	162
Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (A Gynecologic Oncology Group Study) Gregory P. Sutton, Brian N. Bundy, George Omura, Gynecologic Oncology Gynecological SurgeryMedicineLow Malignant PotentialGynecologyCancer Treatment	1991	74
Stage IB cervical carcinoma: comparison of clinical, MR, and pathologic staging Deborah J. Rubens, Thornbury, Cynthia Angel, American Journal of Roentgenology	1988	67
Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer Philip M. Dvoretsky, Keith Richards, Cynthia Angel, Human Pathology Survival TimeMedicineCancer ManagementGynecologyCancer Treatment	1988	63
Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology André Konski, Colin Poulter, Henry Keys, International Journal of Radiation OncologyBiologyPhysics Gynecological SurgeryGenitourinary CancerTreatment AdvantageMedicinePathology	1988	48
Mitoxantrone in the Treatment of Advanced Uterine Sarcoma Hyman B. Muss, B. Bundy, Leon L. Adcock, American Journal of Clinical Oncology	1990	40

Page 1